These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21176510)

  • 21. A novel recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing human granulocyte macrophage colony-stimulating factor and Mycobacterium tuberculosis early secretory antigenic target 6 complex augments Th1 immunity.
    Yang X; Bao L; Deng Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):511-8. PubMed ID: 21676888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of granulysin and perforin as candidate biomarkers for protection following vaccination with Mycobacterium bovis BCG or M. bovisDeltaRD1.
    Capinos Scherer CF; Endsley JJ; de Aguiar JB; Jacobs WR; Larsen MH; Palmer MV; Nonnecke BJ; Ray Waters W; Mark Estes D
    Transbound Emerg Dis; 2009 Aug; 56(6-7):228-39. PubMed ID: 19389081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic tracing and T cell responses following oral vaccination with live Mycobacterium bovis (BCG).
    Dorer DE; Czepluch W; Lambeth MR; Dunn AC; Reitinger C; Aldwell FE; McLellan AD
    Cell Microbiol; 2007 Feb; 9(2):544-53. PubMed ID: 17018037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of Mycobacterium bovis Bacillus Calmette-Guérin in white-tailed deer (Odocoileus virginianus) after oral or parenteral vaccination.
    Palmer MV; Thacker TC; Waters WR; Robbe-Austerman S; Lebepe-Mazur SM; Harris NB
    Zoonoses Public Health; 2010 Dec; 57(7-8):e206-12. PubMed ID: 20707863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein.
    Shi C; Chen L; Chen Z; Zhang Y; Zhou Z; Lu J; Fu R; Wang C; Fang Z; Fan X
    Vaccine; 2010 Jul; 28(32):5237-44. PubMed ID: 20538090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N
    Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
    Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
    Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4⁺IL-17⁺TNF⁺IL-2⁺ T cells.
    Cruz A; Torrado E; Carmona J; Fraga AG; Costa P; Rodrigues F; Appelberg R; Correia-Neves M; Cooper AM; Saraiva M; Pedrosa J; Castro AG
    Vaccine; 2015 Jan; 33(1):85-91. PubMed ID: 25448107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children.
    Anuradha B; Rakh SS; Ishaq M; Murthy KJ; Valluri VL
    Pediatr Infect Dis J; 2008 Apr; 27(4):325-9. PubMed ID: 18379373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
    Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium bovis bacillus Calmette-Guérin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production.
    Martino A; Badell E; Abadie V; Balloy V; Chignard M; Mistou MY; Combadière B; Combadière C; Winter N
    J Immunol; 2010 Feb; 184(4):2038-47. PubMed ID: 20083674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro T-cell profile induced by BCG Moreau in healthy Brazilian volunteers.
    Ponte C; Peres L; Marinho S; Lima J; Siqueira M; Pedro T; De Luca P; Cascabulho C; Castello-Branco LR; Antas PR
    Hum Vaccin Immunother; 2015; 11(2):450-7. PubMed ID: 25483636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of diesel exhaust particulate on bacillus Calmette-Guerin lung infection in mice and attendant changes in lung interstitial lymphoid subpopulations and IFNgamma response.
    Saxena RK; Saxena QB; Weissman DN; Simpson JP; Bledsoe TA; Lewis DM
    Toxicol Sci; 2003 May; 73(1):66-71. PubMed ID: 12700415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.